Devex: A proposed novel approach to TB drug financing
“Global health experts will be discussing a novel approach to bring better tuberculosis drugs to the market on Sunday, the eve of the 72nd World Health Assembly. … The proposal, called ‘Market-Driven, Value-Based Advance Commitment,’ or MVAC, [which was designed by experts at the Center for Global Development (CGD) and the Office of Health Economics in the U.K.,] builds on a decade-old model that Gavi, the Vaccine Alliance and a number of donors tried to implement to bring pneumococcal vaccines in the low- and middle-income market…” (Ravelo, 5/17).